Scientists have discovered a new pathway in the brain that can be manipulated to alleviate depression. The pathway offers a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed. New antidepressant options are important because a significant number of patients don’t adequately improve with currently available antidepressant drugs.
Depression is like a kick while you’re already down. Sometimes there is no real reason for it, sometimes it is triggered by some serious life issues, but clinical depression always has very real neurological roots. Unfortunately, while we know that certain areas of the brain are smaller in a depressed person, we don’t know why or what effect it has on a person. Worse, SSRI’s the “gold standard” for depression can have no — or worse ill — effects on the person taking the drugs.
Think you know what causes depression? Well unfortunately scientists don’t have the exact answer, surprised? That’s not the only problem, there is an ever growing concern that we live in an over medicated society and a newly released study doesn’t paint a better picture. About 15 percent of women in the United States suffer from anxiety disorders and depression during their pregnancies, and many are prescribed antidepressants. However little is known about how early exposure to these medications might affect their offspring as they mature into adults.